When Organogenesis was founded in the early 1980s, the company consisted of a few scientists. Today, we are one of the leading regenerative medicine companies, with more than 600 employees worldwide - and growing.
Organogenesis has pioneered the development of novel products based on advances in cell biology and regenerative medicine. In addition, we have launched the industry's first commercially successful products.
To sustain our momentum, we aim to attract and retain the most talented people who are dedicated to our mission of bringing the medical marvel of regenerative medicine products to patients worldwide and standardizing their use in everyday medical care.